Measure Description
Percentage of patients aged 18 years and older, who report benign paroxysmal positional vertigo (BPPV)-related symptoms and are screened with a dizziness assessment questionnaire and undergo positional nystagmus testing AND, if diagnosed or identified with BPPV, received a BPPV-related care plan and vestibular intervention(s) or treatment(s) AND who have an improvement in nystagmus or report an improvement in BPPV-related symptoms, and report a meaningful clinically important difference (MCID) improvement of BPPV-related quality of life (QoL).
Denominator
Strata 1: Patients aged 18 years and older with a patient encounter
Strata 2: Patients aged 18 years and older who are screened with a dizziness assessment questionnaire, undergo positional nystagmus testing, and are identified or diagnosed with BPPV
Strata 3: Patients aged 18 years and older who received a BPPV-related care plan and vestibular intervention(s) or treatment(s)
Numerator
Strata 1: Patients who do/do not report BPPV-related symptoms AND if report symptoms are screened with a dizziness assessment questionnaire AND undergo positional nystagmus testing AND are identified or diagnosed with BPPV
Strata 2: Patients who received vestibular intervention(s) or treatment(s) within 30 days of the documented BPPV-related care plan
Strata 3: Patients who report a MCID improvement of BPPV-related QoL
Denominator Exclusions
N/A
Denominator Exceptions
Strata 1: Patient reported BPPV-related symptoms and was evaluated with positional nystagmus testing and declined to complete the dizziness assessment questionnaire.
OR
Patient reported BPPV-related symptoms and completed a dizziness assessment questionnaire and declined to complete the positional nystagmus testing
Strata 2: Patient received a BPPV-related care plan within 60 days of the index event
AND
Patient was referred to a qualified practitioner for vestibular intervention(s) or treatment(s) within 60 days of the index event OR additional vestibular evaluation, referral, intervention(s), or treatment(s) were recommended within 60 days of the index event.
OR
Patient received a BPPV-related care plan within 60 days of the index event AND
Patient declined vestibular intervention(s) or treatment(s).
Strata 3: Patient declined to complete a post-vestibular intervention(s) or treatment(s) dizziness assessment questionnaire within 60 days of the index event..
OR
Patient screened with a dizziness assessment questionnaire and was diagnosed or identified with BPPV in at least one ear but declined vestibular intervention(s) or treatment(s) within 60 days of the index event
Numerator Exclusions
N/A
NQF ID Number
N/A
NQS Domain
Effective Clinical Care
High Priority Measure
Yes
Measure Type
Patient Reported Outcome (PRO)
Includes Telehealth?
Yes
Inverse Measure
No
Proportional Measure
Yes
Continuous Variable Measure
No
Ratio Measure
No
Number of performance rates to be calculated and submitted
3
Risk-Adjusted Status?
No